Conditions for modifying intraocular lenses as drug carriers for methotrexate using poly (lactic-co-glycolic acid).

Clarissa BillStefan Kassumeh Christina HilterhausNatalie TersiArne J SpeidelAndreas OhlmannSiegfried PriglingerClaudia PriglingerArmin WolfChristian Maximilian Wertheimer

Published in: European journal of ophthalmology (2024)

After determination of the required physicochemical manufacturing conditions, a drug releasing IOL was designed. A favourable release profile in an ocular pharmacokinetics model could be shown.

Keyphrases

high dose
adverse drug
emergency department
mass spectrometry